PL Growth

$24,971P30FY2016CANIH

Salk Institute For Biological Studies, La Jolla CA

Investigators

Linked publications & trials

Paper 39713479 Paper 39606484 Paper 39574610 Paper 39497054 Paper 39455851 Paper 39388266 Paper 39383000 Paper 39232281 Paper 39122697 Paper 39087348 Paper 38951660 Paper 38915491 Paper 38908369 Paper 38890299 Paper 38843835 Paper 38816388 Paper 38754421 Paper 38712081 Paper 38704507 Paper 38693003 Paper 38653806 Paper 38580077 Paper 38508192 Paper 38500536 Paper 38498576 Paper 38418648 Paper 38377195 Paper 38355755 Paper 38349791 Paper 38332353 Paper 38241033 Paper 38177161 Paper 38165941 Paper 38164626 Paper 38057551 Paper 38051586 Paper 38039131 Paper 38013994 Paper 38007688 Paper 38001006 Paper 37951043 Paper 37932264 Paper 37832945 Paper 37824674 Paper 37820583 Paper 37693382 Paper 37673892 Paper 37611587 Paper 37490905 Paper 37398222 Paper 37392742 Paper 37317784 Paper 37221017 Paper 37197878 Paper 37192160 Paper 37172564 Paper 37134162 Paper 37097512 Paper 36865315 Paper 36841488 Paper 36755096 Paper 36715544 Paper 36635501 Paper 36631217 Paper 36599300 Paper 36599299 Paper 36508655 Paper 36477537 Paper 36472212 Paper 36398769 Paper 36351387 Paper 36315049 Paper 36277993 Paper 36266352 Paper 36253572 Paper 36229429 Paper 36198801 Paper 36198291 Paper 36191258 Paper 36191221 Paper 36170373 Paper 36164267 Paper 36161959 Paper 36115594 Paper 36108220 Paper 36054194 Paper 36041455 Paper 36029998 Paper 36008083 Paper 35987203 Paper 35967387 Paper 35948563 Paper 35947647 Paper 35942952 Paper 35941112 Paper 35940205 Paper 35931086 Paper 35931082 Paper 35915085 Paper 35897143

Abstract

The overall scientific goal of the Growth Control and Genomic Stability Program is to understand mechanisms of proliferation, transcriptional regulation of oncogenic signaling pathways, DNA damage response and checkpoint activation, maintenance of genomic integrity and telomere function, and how these processes are disrupted or altered in cancer cells. Genomic instability is one of the key contributors to cancer progression and the genesis of tumor heterogeneity, and can engender either sensitivity or resistance to targeted and dastogenic cancer therapies. The members of this program study diverse aspects of how normal somatic cells, stem cells, and cancer cells respond to DNA damage, maintain genomic integrity, and respond to traditional and targeted chemotherapies. The functions of p53 in cell cycle checkpoint control and in diverse stress responses, and the use of adenovirus early proteins to interrogate cell signaling pathways and p53 checkpoint signaling comprise areas of significant focus of the program with opportunities for clinical translation. Chemical genetics is being used to study cellular signaling pathways that drive cancer cell proliferation. Other important topics include molecular mechanisms of transcriptional regulation of oncogenic pathways and of tumor suppressor gene expression, how nuclear pore subunits regulate gene expression, and the relationship of fetal mammary stem cells to stem-like cells in breast cancer. The program includes nine members from five different Laboratories (Departments), see the following page for a list of personnel. The NCI and other peer-reviewed cancer related support (direct costs) for the last budget year was $3,049,383. The substantial NIH and other federal support for this program is outlined in the table of externally funded research projects. The total number of cancer-relevant publications by members of this program in the last grant period (2008- 2012) was 132. Of the total publications, 1% were intraprogrammatic and 13% were interprogrammatic.

View original record on NIH RePORTER →